Latest Breaking News On - Global multiple sclerosis - Page 1 : comparemela.com

Merck KGaA, Darmstadt, Germany, Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare News provided by Share this article Share this article DARMSTADT, Germany, Feb. 4, 2021 /PRNewswire/  Merck KGaA, Darmstadt, Germany, which operates its Healthcare business sector as EMD Serono in the US and Canada, today announced that Rehan Verjee has made the decision to leave his position as President of EMD Serono and Global Head of Innovative Medicine Franchises, to pursue an opportunity outside of the Company that will soon be announced.  He will be succeeded by Andrew Paterson, who is currently Senior Vice President and Head of both the Global Multiple Sclerosis (MS) Franchise and the MS business unit in the United States.

United statesMerck kgaPeter guenterRehan verjeeAndrew patersonHealthcare executive committeeMerck kgaaGroup websiteGlobal headInnovative medicine franchisesSenior vice presidentGlobal multiple sclerosisHealthcare executiveExecutive boardInnovative medicinesNorth american